Bristol-Myers Squibb (BMY) Files Investor Presentation, Letter From Board Related to Pending Celgene (CELG) Deal

March 6, 2019 7:10 AM
Bristol-Myers Squibb Company (NYSE: BMY) today filed an investor presentation with the Securities and Exchange Commission (SEC), and the Board ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Mergers and Acquisitions

Next Articles